Rosichini M, Catanoso M, Screpanti I, Felli M, Locatelli F, Velardi E
Front Immunol. 2022; 13:920306.
PMID: 35734178
PMC: 9207182.
DOI: 10.3389/fimmu.2022.920306.
Borelli A, Irla M
Cell Death Differ. 2021; 28(8):2305-2314.
PMID: 34290396
PMC: 8329281.
DOI: 10.1038/s41418-021-00834-8.
Gubernatorova E, Polinova A, Petropavlovskiy M, Namakanova O, Medvedovskaya A, Zvartsev R
Cancers (Basel). 2021; 13(8).
PMID: 33917839
PMC: 8068266.
DOI: 10.3390/cancers13081775.
Malaviya A, Mehra N
Indian J Med Res. 2018; 148(3):263-278.
PMID: 30425216
PMC: 6251261.
DOI: 10.4103/ijmr.IJMR_1471_18.
Parikh S
Curr Opin Hematol. 2017; 24(5):432-438.
PMID: 28582314
PMC: 5777595.
DOI: 10.1097/MOH.0000000000000361.
Lymphotoxin and TNF: how it all began-a tribute to the travelers.
Ruddle N
Cytokine Growth Factor Rev. 2014; 25(2):83-9.
PMID: 24636534
PMC: 4027955.
DOI: 10.1016/j.cytogfr.2014.02.001.
Lymphotoxin α revisited: general features and implications in rheumatoid arthritis.
Calmon-Hamaty F, Combe B, Hahne M, Morel J
Arthritis Res Ther. 2011; 13(4):232.
PMID: 21861866
PMC: 3239340.
DOI: 10.1186/ar3376.
DNA gene vaccination for HIV.
Kim J, Weiner D
Springer Semin Immunopathol. 1997; 19(2):175-94.
PMID: 9406345
DOI: 10.1007/BF00870267.
Antilymphocyte serum and tissue culture used to investigate role of cell-mediated response in viral encephalitis in mice.
Rook G, Webb H
Br Med J. 1970; 4(5729):210-2.
PMID: 5472783
PMC: 1819743.
DOI: 10.1136/bmj.4.5729.210.
Mechanisms of lymphocyte-induced cell and tissue destruction in vitro.
GRANGER G
Am J Pathol. 1970; 60(3):469-82.
PMID: 5459751
PMC: 2033037.
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin.
KOLB W, GRANGER G
Proc Natl Acad Sci U S A. 1968; 61(4):1250-5.
PMID: 5249808
PMC: 225248.
DOI: 10.1073/pnas.61.4.1250.
Lymphocyte-mediated cytotoxicity in vitro. Effect of enhancing antisera.
Klein Jr W
J Exp Med. 1971; 134(5):1238-52.
PMID: 5112204
PMC: 2139019.
DOI: 10.1084/jem.134.5.1238.
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity.
Dutton R
J Exp Med. 1972; 136(6):1445-60.
PMID: 4641854
PMC: 2139330.
DOI: 10.1084/jem.136.6.1445.
Sensitivity of non-human cells to human lymphocyte 'proliferation inhibitory factor' (PIF) in vitro.
Badger A, COOPERBAND S, Merluzzi V, Green J
Clin Exp Immunol. 1973; 15(3):435-44.
PMID: 4202952
PMC: 1553900.
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.
Vilcek J, Palombella V, Swenson C, Feinman R, Hirai M, Tsujimoto M
J Exp Med. 1986; 163(3):632-43.
PMID: 3512757
PMC: 2188056.
DOI: 10.1084/jem.163.3.632.
Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon.
Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussia B
J Exp Med. 1986; 164(4):1206-25.
PMID: 3093627
PMC: 2188407.
DOI: 10.1084/jem.164.4.1206.
The role of tumor necrosis factor and interleukin 1 in the immunoinflammatory response.
Larrick J, Kunkel S
Pharm Res. 1988; 5(3):129-39.
PMID: 3072553
DOI: 10.1023/a:1015904721223.
Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome.
Lau A, Livesey J
J Clin Invest. 1989; 84(3):738-43.
PMID: 2503543
PMC: 329714.
DOI: 10.1172/JCI114231.
Lymphotoxin. A review and analysis.
Rosenau W, Tsoukas C
Am J Pathol. 1976; 84(3):580-96.
PMID: 786035
PMC: 2032532.
I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors.
Ryzewska A, Darbrowska B
Immunology. 1976; 31(5):677-87.
PMID: 136420
PMC: 1445133.
